Otsuka Holdings Co., Ltd. - Unsponsored ADR (OTCMKTS:OTSKY - Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $28.69, but opened at $27.68. Otsuka shares last traded at $27.68, with a volume of 150 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Zacks Research upgraded Otsuka to a "strong sell" rating in a research report on Monday, August 11th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has an average rating of "Sell".
Get Our Latest Stock Analysis on OTSKY
Otsuka Stock Down 0.7%
The business has a 50 day moving average price of $25.97 and a 200 day moving average price of $25.04. The stock has a market cap of $29.60 billion and a P/E ratio of 0.18.
About Otsuka
(
Get Free Report)
Otsuka Holdings Co, Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices.
Further Reading
Before you consider Otsuka, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Otsuka wasn't on the list.
While Otsuka currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
